Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Elliott

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Australian and New Zealand Journal of Medicine|May 26, 1999
Anti-transglutaminase antibodies and coeliac diseaseA Miller, W Paspaliaris, P R Elliott, et al.
The European Respiratory Journal|March 1, 1997
Commercial plasma alpha1-antitrypsin (Prolastin) contains a conformationally inactive, latent componentD A Lomas, P R Elliott, R W Carrell
JAMA|September 27, 1985
US medical school financesH P Jolly, L Taksel, P R Elliott, et al.
Australian and New Zealand Journal of Medicine|December 1, 1992
Autoantibodies to neutrophil cytoplasmic (ANCA) and endothelial cell surface antigens (AECA) in chronic inflammatory bowel diseaseE Romas, B Paspaliaris, A J d'Apice, et al.
British Medical Journal (Clinical Research Ed.)|July 20, 1985
Prognosis of colonic Crohn's diseaseP R Elliott, J K Ritchie, J E Lennard-Jones
Journal of Gastroenterology and Hepatology|September 14, 2001
Rapid response of severe refractory metastatic Crohn's disease to infliximabA M Miller, P R Elliott, R Fink, et al.
The American Journal of Emergency Medicine|July 1, 1996
Telemedicine using the internetL G Yamamoto, P R Elliott, M I Herman, et al.
Protein Science : a Publication of the Protein Society|August 10, 2000
Topography of a 2.0 A structure of alpha1-antitrypsin reveals targets for rational drug design to prevent conformational diseaseP R Elliott, X Y Pei, T R Dafforn, et al.
Nature Structural Biology|August 1, 1996
Inhibitory conformation of the reactive loop of alpha 1-antitrypsinP R Elliott, D A Lomas, R W Carrell, et al.
Gut|November 15, 2005
Severe recurrent Crohn's disease of the ileocolonic anastomosis disappearing completely with antibacterial therapyP R Elliott, G T C Moore, S J Bell, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Australian and New Zealand Journal of Medicine|May 26, 1999
Anti-transglutaminase antibodies and coeliac diseaseA Miller, W Paspaliaris, P R Elliott, et al.
The European Respiratory Journal|March 1, 1997
Commercial plasma alpha1-antitrypsin (Prolastin) contains a conformationally inactive, latent componentD A Lomas, P R Elliott, R W Carrell
JAMA|September 27, 1985
US medical school financesH P Jolly, L Taksel, P R Elliott, et al.
Australian and New Zealand Journal of Medicine|December 1, 1992
Autoantibodies to neutrophil cytoplasmic (ANCA) and endothelial cell surface antigens (AECA) in chronic inflammatory bowel diseaseE Romas, B Paspaliaris, A J d'Apice, et al.
British Medical Journal (Clinical Research Ed.)|July 20, 1985
Prognosis of colonic Crohn's diseaseP R Elliott, J K Ritchie, J E Lennard-Jones
Journal of Gastroenterology and Hepatology|September 14, 2001
Rapid response of severe refractory metastatic Crohn's disease to infliximabA M Miller, P R Elliott, R Fink, et al.
The American Journal of Emergency Medicine|July 1, 1996
Telemedicine using the internetL G Yamamoto, P R Elliott, M I Herman, et al.
Protein Science : a Publication of the Protein Society|August 10, 2000
Topography of a 2.0 A structure of alpha1-antitrypsin reveals targets for rational drug design to prevent conformational diseaseP R Elliott, X Y Pei, T R Dafforn, et al.
Nature Structural Biology|August 1, 1996
Inhibitory conformation of the reactive loop of alpha 1-antitrypsinP R Elliott, D A Lomas, R W Carrell, et al.
Gut|November 15, 2005
Severe recurrent Crohn's disease of the ileocolonic anastomosis disappearing completely with antibacterial therapyP R Elliott, G T C Moore, S J Bell, et al.
Pageof 4